Direct activation of TERT transcription by c-MYC
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The MYC proto-oncogene encodes a ubiquitous transcription factor (c-MYC) involved in the control of cell proliferation and differentiation. Deregulated expression of c-MYC caused by gene amplification, retroviral insertion, or chromosomal translocation is associated with tumorigenesis. The function of c-MYC and its role in tumorigenesis are poorly understood because few c-MYC targets have been identified. Here we show that c-MYC has a direct role in induction of the activity of telomerase, the ribonucleoprotein complex expressed in proliferating and transformed cells, in which it preserves chromosome integrity by maintaining telomere length. c-MYC activates telomerase by inducing expression of its catalytic subunit, telomerase reverse transcriptase (TERT). Telomerase complex activity is dependent on TERT, a specialized type of reverse transcriptase. TERT and c-MYC are expressed in normal and transformed proliferating cells, downregulated in quiescent and terminally differentiated cells, and can both induce immortalization when constitutively expressed in transfected cells. Consistent with the recently reported association between MYC overexpression and induction of telomerase activity, we find here that the TERT promoter contains numerous c-MYC-binding sites that mediate TERT transcriptional activation. c-MYC-induced TERT expression is rapid and independent of cell proliferation and additional protein synthesis, consistent with direct transcriptional activation of TERT. Our results indicate that TERT is a target of c-MYC activity and identify a pathway linking cell proliferation and chromosome integrity in normal and neoplastic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The activation of hTERT transcription is driven by the c-Myc oncogene forming a heterodimer, c-Myc/Max, that binds to E-box sequences in the promoter of hTERT [248,249,250]”
From The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis (2021) · cites this paper as [248]
In the citing paper
“The TERT promoter is controlled in some contexts by the c-Myc oncogene, which recognizes E-boxes within the promoter (56,57), and by estrogen receptor and Sp1 (58).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [56]
In the citing paper
“There are at least five GC-boxes within the core promoter of hTERT, proven by EMSA to bind Sp1.(22) Introduction of mutations in these GC-boxes significantly decreased the transcriptional activity of the promoter, while overexpression of Sp1 in cells that contain relatively low levels of endogenous Sp1 enhanced the promoter activity.(17)”
From Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers (2008) · cites this paper as [17]
In the citing paper
“In fact, several groups confirmed that c-Myc binds to E-boxes on the hTERT promoter and activates the transcription (15)(16)(17)(18)(19) which established the scenario that c-Myc is a key regulator of hTERT transcription during carcinogenesis.”
From Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers (2008) · cites this paper as [17]
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 1×
“Contrary to early reports suggesting a specific association between telomerase activity and cell immortalization or transformatio”
BackgroundExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Self-citationMeyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784
Reverse Transcriptase Motifs in the Catalytic Subunit of Telomerase
Lingner, J., Hughes, T. R., Shevchenko, A., Mann, M., Lundblad, V., & Cech, T. R. (1997) · Science · doi:10.1126/science.276.5312.561 · Cited by 1,269
Self-citationLuciferase reporter gene vectors for analysis of promoters and enhancers.
Nordeen, S. K. (1988) · PubMed · Cited by 994
Littlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M. G., & Evan, G. I. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.10.1686 · Cited by 781
Proteins of the Myc Network: Essential Regulators of Cell Growth and Differentiation
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60353-x · Cited by 779
Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity
Ayer, D. E., Kretzner, L., & Eisenman, R. N. (1993) · Cell · doi:10.1016/0092-8674(93)90661-9 · Cited by 703
Wang, J., Xie, L. Y., Allan, S., Beach, D., & Hannon, G. J. (1998) · Genes & Development · doi:10.1101/gad.12.12.1769 · Cited by 653
Cited by
Items 801–900 of 911
The role of histone modification and alternative splicing
Ge, Z. (2008) · Figshare
Cellular and systemic defense system against age-promoting stimuli.
Isobe, K., Ito, S., Haneda, M., & Ishida, Y. (2006) · PubMed · doi:10.18999/nagjms.68.1-2.9
New therapeutic options for the treatment of lung cancer by telomerase inhibition
Taetz, S. (2008) · Publications of the UdS (Saarland University) · doi:10.22028/d291-22565
Genetic Profiling: Searching for Novel Genetic Aberrations in Glioblastoma
Jamshidi, P., & Clark, C. (2013) · InTech eBooks · doi:10.5772/53387
Telomerase reverse transcriptase (TERT) : promoter mutation and novel function in human cancer
Liu, T. (2014) · Figshare · Cited by 1
Transcriptional Regulation of Human Telomerase
Farsetti, A., & Cong, Y. (2012) · Wiley eBooks · doi:10.1002/9781118268667.ch5
New Techniques in the Generation of Induced Pluripotent Stem Cells
Raymond, C. B., Ellen, L., & Peter, J. (2011) · InTech eBooks · doi:10.5772/25208
Cell. proliferation, telomerase, and cancer
Elmore, L. W., & Holt, S. E. (2001) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(01)08005-1
Nodal aggressive non-Hodgkin’s lymphoma in the adult: a review article
Martelli, M., Corradini, P., Santo, A., Gaïdano, G., Gianni, A. M., Musto, P., Pileri, S. A., Rambaldi, A., Zinzani, P. L., & Tura, S. (2005) · Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) · doi:10.4081/hmr.v1i12.355
Growth factor-mediated telomerase activity in ovarian cancer cells
Bermudez, Y. (2007) · Digital Commons - University of South Florida (University of South Florida)
Chromosomal alterations and telomere dysfunction in breast tumours
Böðvarsdóttir, S. K. (2008) · Skemman
Molecular definition of Burkitt Lymphoma
Boerma, E.-J. G. (2009) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Phosphorylation of cell cycle proteins at senescence
Sandhu, C. (2004) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(04)16002-1
Developing Novel Cell Sources for Transplantation in Parkinson’s Disease
Christophersen, N. S., Correia, A. S., Roybon, L., Li, J., & Brundin, P. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-147-5_2
Regulation of Myc oncoprotein function by E3 ubiquitin ligases
Fahlén, S. (2008) · Epsilon Open Archive (Sveriges lantbruksuniversitet biblioteket (Swedish University of Agricultural Sciences))
Development of adenoviral vectors for monitoring telomerase activity in living cells
Edqvist, A. (2007) · Lund University Publications (Lund University)
Molecular Genetic Studies on Prostate and Penile Cancer
Andersson, P. (2008) · DiVA (Digitala Vetenskapliga Arkivet)
Sinacore, M. S., Charlebois, T. S., Drapeau, D., Leonard, M. W., Harrison, S., & Adamson, S. R. (2010) · Wiley eBooks · doi:10.1002/9780470054581.eib597
Hultdin, M. (2003) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 1
Normal and Neoplastic Stem Cells
Schulenburg, A., & Marian, B. (2012) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.201100020
Correction: Telomere Dynamics in Human Cells Reprogrammed to Pluripotency
Suhr, S. T., Chang, E. A., Rodriguez, R. M., Wang, K., Ross, P. J., Beyhan, Z., Murthy, S., & Cibelli, J. B. (2010) · PLoS ONE · doi:10.1371/annotation/c786d141-fd0f-45fd-80ec-96d80be620dc
Regulation of telomerase activity by recombinant human tumor necrosis factor in vitro
Xie, W., Lin, Y., Zhang, X., Chen, W., Zhang, X., Zhang, Z., & Wang, H. (2001) · Chinese Journal of Digestive Diseases · doi:10.1046/j.1443-9573.2001.00056.x
Downregulation of Telomerase in CoCl2-Induced Apoptosis of Myeloid Leukemic Cells
Xu, Y.-B., Zhang, J., Bendirdjian, E. S., Wu, Y., & Chen, G. (2008) · The Open Hematology Journal · doi:10.2174/1874276900802010074
Assessment of therapeutic targets in experimental models of Myc-induced lymphoma
Forshell, L. P. (2011)
HUMAN 15-LIPOXYGENASE-1 AND TELOMERASE GENE EXPRESSION IN CANCER AND INFLAMMATION
Liu, C. (2008) · Figshare
CORE BREAST CANCER ASSOCIATED MOLECULES: The Essence
Promkan, M., & Patmasiriwat, P. (2013) · doi:10.14456/tjg.2013.144
Roles of Myc and Mad in cell cycle and apoptosis
Albihn, A. (2006) · Figshare
ANGIOSTATIC MECHANISMS OF ENDOGENOUS ANGIOGENESIS INHIBITORS
Veitonmäki, N. (2003) · Figshare
Hultquist, A. (2001) · DiVA (Digitala Vetenskapliga Arkivet)
Ras-MAPK Signaling in Differentiating SH-SY5Y Human Neuroblastoma Cells
Olsson, A. (2000) · DiVA (Digitala Vetenskapliga Arkivet)
STUDIES ON THE MECHANISMS OF CARCINOGENESIS AND CANCER CELL DEATH
Li, Q. (2013) · Figshare
Zhu-hu, L., Lee, M., Jeon, H.-J., Hong, C.-P., Park, C.-Y., & Chung, C.-H. (2005) · The Korean Journal of Hematology · doi:10.5045/kjh.2005.40.3.149
hTERT gene inhibition studies in cancer cells by using polysaccharide lentina
Sreenivasulu, K., Vijayalakshmi, M., & Rao, K. R. S. S. (2011) · Journal of Medical Genetics and Genomics · doi:10.5897/jmgg.9000025 · Cited by 2
Telomeres, Telomerase, and DNA Damage Response in Cancer Therapy
Tamakawa, R., Fleisig, H. B., & Wong, J. M. Y. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4741-2_11
MaCharles, J., FuchsEdward, S., GiovannucciPeter, L., LiuLin, K., & Jiao, C. (2012)
TELOMERASE ACTIVATION AND ITS CLINICAL IMPLICATIONS IN HUMAN THYROID TUMORS
Wang, N. (2015) · Figshare
Xin, X., Ludewig, G., Schnoor, J. L., Klingelhutz, A. J., Robertson, L. W., & Irish, E. E. (2015) · doi:10.17077/etd.n2vz9u6t · Cited by 1
Regulatory mechanism of telomerase activity in 4-NQO-induced carcinogenesis of rat tongue.
Nakano, S. (2001) · Japanese Journal of Oral & Maxillofacial Surgery · doi:10.5794/jjoms.47.763
Molekulare Grundlagen des sporadischen Mammakarzinoms
Kuschel, B., & Beckmann, M. W. (2002) · Springer eBooks · doi:10.1007/978-3-642-56297-6_3
Signalling pathways in renal cell carcinoma with a focus on telomerase regulation
Sitaram, R. T. (2010)
Novel strategy to inhibit the oncogenic transcription factor c-Myc in triple-negative breast cancer
Mejzini, R. (2016) · Murdoch University Research Portal
Wang, Q., Zhuang, L., Li, P., Niu, Q., Zhu, P., He, M., Jiang, H., Liu, C., Wang, M., Chen, L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00874-6
Neoplasia of the Gastrointestinal Tract
Margalit, O., & DuBois, R. N. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch31
Multi-platform Genomic Data Analysis Using Multimodal Autoencoder
CHEN, H., & Shi, J. (2017) · DEStech Transactions on Computer Science and Engineering · doi:10.12783/dtcse/cib2015/16153
Food Science Research on Anticancer Effects of Fat-soluble Nutrients
Eitsuka, T. (2017) · Nippon Eiyo Shokuryo Gakkaishi · doi:10.4327/jsnfs.70.263
Wicaksono, B. D. (2020) · ERA · doi:10.7488/era/429
Convergent mutations in tissue-specific regulatory regions reveal novel cancer driversPreprint
Sinnott-Armstrong, N., Seoane, J. A., Sallari, R. C., Pritchard, J. K., Curtis, C. N., & Snyder, M. P. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.21.239954 · Cited by 1
See, Y. X. (2021) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/154939
Sinacore, M. S., Charlebois, T. S., Drapeau, D., Leonard, M. W., Harrison, S., & Adamson, S. R. (2000) · Wiley eBooks · doi:10.1002/0471250570.spi044
Cerone, M. A., & Bacchetti, S. (2006) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200500042
Asamitsu, S. (2020) · Springer theses · doi:10.1007/978-981-15-7716-1_1
Hickson, I. D., & Mankouri, H. W. (2014) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718235134.793493488
SUGIMOTO, M. (2010) · KAGAKU TO SEIBUTSU · doi:10.1271/kagakutoseibutsu.48.630
Nakagawa, K., Miyazawa, T., & Eitsuka, T. (2008) · CRC Press eBooks · doi:10.1201/9781420080391.ch16
Telomerase Reverse Transcriptase in Humans: From Biology to Cancer Immunity
Dosset, M., Castro, A., Su, X., Carter, H. K., & Zanetti, M. (2022) · Interdisciplinary cancer research · doi:10.1007/16833_2022_49
E4F1 and ZNF148 are transcriptional activators of the A57C and wildtype TERT promoterPreprint
Chua, B. H., Ferry, L., Domrane, C., Anuar, N. Z., Wittek, A., Jha, S., Butter, F., Tenen, D. G., Defossez, P., & Kappei, D. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.13.523884
dos Santos, G. A. G. D. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2023.tde-23082023-144910
Advanced Pathology Classification Toward Precision Stratification of Neuroblastic Tumors
Shimada, H., & Ikegaki, N. (2024) · Pediatric oncology · doi:10.1007/978-3-031-51292-6_2
The Genetic Basis of Neuroendocrine Neoplasms
Wasylishen, A. R., Gay, C. M., & Halperin, D. M. (2024) · Endocrinology · doi:10.1007/978-3-030-67823-4_4-1
Overlapping Gene Expression and Molecular Features in High-Grade B-Cell Lymphoma
Faißt, K. D., Husemann, C. C., Kleo, K., Twardziok, M., & Hummel, M. (2024) · Journal of Molecular Pathology · doi:10.3390/jmp5040028
Azitoune, S., Kabbaj, K., Saghir, S., & Abilkassem, R. (2024) · International Journal of Innovative Science and Research Technology (IJISRT) · doi:10.38124/ijisrt/ijisrt24oct261
Telomere, DNA Damage Response, and Nanomedicine: A Triad for Cancer Treatment Innovation
Afshar, Y., Sharif, H., & Rezaei, N. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_486
Advancing In Vitro Tools for Oncologic Research in Cats and Dogs
He, C., & Rottenberg, S. (2025) · Veterinary Sciences · doi:10.3390/vetsci12090815
Infection-Induced Telomere Length Variation: Insights into Pathogenesis of Koala Retrovirus
Cheung, H. M., Lin, S. W. J., Nguyen, H. T. H., Stephenson, T., Speight, N., & Hemmatzadeh, F. (2025) · Viruses · doi:10.3390/v17111510
The Genetic Basis of Neuroendocrine Neoplasms
Wasylishen, A. R., Gay, C. M., & Halperin, D. M. (2025) · Endocrinology · doi:10.1007/978-3-031-83281-9_4
Bokhari, F. F. (2014) · The University of Queensland · doi:10.14264/uql.2014.377
Post-translational regulation of Myc oncoprotein function
Bahram, F. (2004) · Epsilon Open Archive (Sveriges lantbruksuniversitet biblioteket (Swedish University of Agricultural Sciences))
Additional file 2 of NIPSNAP1 directs dual mechanisms to restrain senescence in cancer cells
Gao, E., Sun, X., Thorne, R. F., Zhang, X. D., Li, J., Shao, F., Ma, J., & Wu, M. (2024) · Figshare · doi:10.6084/m9.figshare.26598311
Suvilesh, K. N., Nussbaum, Y. I., Radhakrishnan, V., Manjunath, Y., Avella, D. M., Staveley-O’Carroll, K. F., Kimchi, E. T., Chaudhuri, A. A., Shyu, C.-R., Li, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19351107
Additional file 8 of NIPSNAP1 directs dual mechanisms to restrain senescence in cancer cells
Gao, E., Sun, X., Thorne, R. F., Zhang, X. D., Li, J., Shao, F., Ma, J., & Wu, M. (2024) · Figshare · doi:10.6084/m9.figshare.26598329
Additional file 9 of NIPSNAP1 directs dual mechanisms to restrain senescence in cancer cells
Gao, E., Sun, X., Thorne, R. F., Zhang, X. D., Li, J., Shao, F., Ma, J., & Wu, M. (2024) · Figshare · doi:10.6084/m9.figshare.26598332
Additional file 5 of NIPSNAP1 directs dual mechanisms to restrain senescence in cancer cells
Gao, E., Sun, X., Thorne, R. F., Zhang, X. D., Li, J., Shao, F., Ma, J., & Wu, M. (2024) · Figshare · doi:10.6084/m9.figshare.26598320
Additional file 6 of NIPSNAP1 directs dual mechanisms to restrain senescence in cancer cells
Gao, E., Sun, X., Thorne, R. F., Zhang, X. D., Li, J., Shao, F., Ma, J., & Wu, M. (2024) · Figshare · doi:10.6084/m9.figshare.26598323
Additional file 7 of NIPSNAP1 directs dual mechanisms to restrain senescence in cancer cells
Gao, E., Sun, X., Thorne, R. F., Zhang, X. D., Li, J., Shao, F., Ma, J., & Wu, M. (2024) · Figshare · doi:10.6084/m9.figshare.26598326
Additional file 1 of NIPSNAP1 directs dual mechanisms to restrain senescence in cancer cells
Gao, E., Sun, X., Thorne, R. F., Zhang, X. D., Li, J., Shao, F., Ma, J., & Wu, M. (2024) · Figshare · doi:10.6084/m9.figshare.26598308
Additional file 4 of NIPSNAP1 directs dual mechanisms to restrain senescence in cancer cells
Gao, E., Sun, X., Thorne, R. F., Zhang, X. D., Li, J., Shao, F., Ma, J., & Wu, M. (2024) · Figshare · doi:10.6084/m9.figshare.26598317
Additional file 1 of Targeting oncogenic TERT promoter variants by allele-specific epigenome editing
Kouroukli, A. G., Rajaram, N., Bashtrykov, P., Kretzmer, H., Siebert, R., Jeltsch, A., & Bens, S. (2023) · Figshare · doi:10.6084/m9.figshare.24628037
Additional file 3 of NIPSNAP1 directs dual mechanisms to restrain senescence in cancer cells
Gao, E., Sun, X., Thorne, R. F., Zhang, X. D., Li, J., Shao, F., Ma, J., & Wu, M. (2024) · Figshare · doi:10.6084/m9.figshare.26598314
Investigation of the TERT promoter DNA methylation status in human cancer
Lee, D. D. (2021) · TSpace (University of Toronto)
Télomerase et destin des tumeurs neuroblastiques
Samy, M. (2010) · theses.fr (ABES) · doi:10.70675/07050b7dz1056z4e65za6f1z34cea95a398b · Cited by 2
Les mécanismes ALTernatifs de maintenance des télomères dans les cellules souches de gliome
Jeitany, M. (2014) · theses.fr (ABES) · doi:10.70675/20330e85z468dz4684z89f5z61818ed2fd80
Modifications de la structure des télomères des cellules cancéreuses par le cis-platine
Saker, L. (2013) · theses.fr (ABES) · doi:10.70675/9697d8c1z994az4647z89dcz3d3f080003c0 · Cited by 1
Déprotection et raccourcissement télomériques dans le carcinome hépatocellulaire
Idrissi, L. M. E. (2013) · theses.fr (ABES) · doi:10.70675/50e7c10bzdd88z48e5zb5c2z8168406fadd4
Etude de l'instabilité génomique et du statut des télomères dans le cancer du sein.
Gay‐Bellile, M. (2017) · theses.fr (ABES) · doi:10.70675/320a4136z144cz4b1ezb9e2z5cc2471afa58
WT1 et régulation de hTERT : cas du neuroblastome et de la leucémie aiguë promyélocytaire
Masserot, C. (2014) · theses.fr (ABES) · doi:10.70675/f3591d6az5305z4025zb7baz03b581ec98d9
Régulation de l’expression de Rnd3 dans les cellules tumorales
Piquet, L. (2016) · theses.fr (ABES) · doi:10.70675/a6c988daz774dz42b5z8c51zc8e035fa9eef
Bousset, L. (2019) · theses.fr (ABES) · doi:10.70675/45b0b676z18daz47a9zbb03zee607f300175 · Cited by 2
Billard, P. (2021) · theses.fr (ABES) · doi:10.70675/7d145f6az2700z4c8bzad56z3286d493fb31
Characterization of the role of telomerase in adult kidney homeostasis and regeneration
Hamidouche, T. (2023) · theses.fr (ABES) · doi:10.70675/09d4231bz139cz44cfz9408z5a93fdb4c0ac
Zhang, L., Liu, Z., Ding, Y., Sun, J., Wu, Y., Shi, J. D., Su, X., Jin, K., Zeng, H., Chang, Y., et al. (2026) · British Journal of Cancer · doi:10.1038/s41416-026-03473-3
Metadata
- Authors
- Wu, K.-J., Grandori, C., Amacker, M., Simon-Vermot, N., Polack, A., Lingner, J., & Dalla-Favera, R.
- Affiliations
- Columbia University (US)
- Fred Hutch Cancer Center (US)
- ISREC Foundation (CH)
- Helmholtz Munich (DE)
- Venue
- Nature Genetics
- Published
- 1999-02
- Volume
- 21
- Issue
- 2
- Pages
- 220-224
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- DOI
- 10.1038/6010
- OpenAlex
- W1547608553
- Cited by
- 893
- References
- 30
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 25 · 2023: 20 · 2022: 24 · 2021: 24 · 2020: 28 · 2019: 21 · 2018: 21 · 2017: 27 · 2016: 31 · 2015: 33 · 2014: 28 · 2013: 26 · 2012: 28
- FWCI
- 32.25
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Institutes of Health (5r01ca037165-17, 5r29ca075125-05)
- National Cancer Institute (CA-20525, CA37165, CA75125-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- c-Myc, telomerase reverse transcriptase, telomerase activation, transcriptional activation, MYC target genes, telomere length, chromosome integrity, cell proliferation, cell immortalization, carcinogenesis
- MeSH terms
- Proto-Oncogene Mas, Binding Sites, Cell Line, DNA-Binding Proteins, Humans, Promoter Regions, Genetic, Proteins, RNA, Transcription, Genetic, Genes, myc, Proto-Oncogene Proteins c-myc, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.